profit from every SEK 100 of sales.
SEK 0SEK 100
Arjo
SEK 36.26+0.00% today
+15.7% in 1 year
1-year low SEK 23.881-year high SEK 36.76
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay SEK 29.57 for every SEK 1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Arjo sold, what it kept, and what it did with the cash.
Sales went from SEK 9.98 billion in 2022 to SEK 11.0 billion in 2025, with SEK 334 million of profit last year.
SalesProfit
Arjo handed back 36% of the cash it generated last year.
SEK 259M
Free cash flow 2025SEK 727M
Bought back its own shares–
Paid as dividendsSEK 259M
Cash vs. debtSEK 836M vs. SEK 5.4B
Arjo vs. similar companies
Arjo grows the slowest of these 5 and is priced in the middle for its profits.
| Company | Profit from SEK 100 of sales | Sales growth a year | Price per SEK 1 of profit |
|---|---|---|---|
| Arjo | 29.6× · Fair price | ||
 McKesson | 26.1× · Fair price | ||
 Cencora | 42.9× · Expensive | ||
 Cardinal Health | 41.2× · Expensive | ||
 Sigma Healthcare | 63.0× · Very expensive |
AI analysis
An AI analyst reads Arjo's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of SEK | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 9,979 | 10,980 | 11,292 | 11,000 | |
| 4,182 | 4,736 | 4,906 | 4,685 | |
| 795 | 984 | 1,027 | 831 | |
| 1,699 | 1,961 | 2,013 | 1,769 | |
| 449 | 480 | 498 | 334 | |
| 1.65 | 1.76 | 1.83 | 1.23 | |
| 41.9% | 43.1% | 43.4% | 42.6% | |
| 8.0% | 9.0% | 9.1% | 7.6% | |
| 4.5% | 4.4% | 4.4% | 3.0% |
Balance sheet
| In millions of SEK | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 15,966 | 15,444 | 16,276 | 14,977 |
| Cash | 949 | 923 | 892 | 836 |
| Total debt | 6,313 | 5,486 | 5,418 | 5,353 |
| Total liabilities | 8,534 | 7,862 | 7,938 | 7,520 |
| 7,432 | 7,582 | 8,338 | 7,457 | |
| 272 | 272 | 272 | 272 | |
| 4.1% | 5.5% | 5.4% | 4.2% | |
| 6.0% | 6.3% | 6.0% | 4.5% |
Cash flow
| In millions of SEK | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 827 | 2,061 | 1,516 | 1,435 | |
| 811 | 679 | 678 | 708 | |
| 16 | 1,382 | 838 | 727 | |
| Dividends paid | 313 | 232 | 245 | 259 |
| – | – | – | – | |
| – | – | – | – |
Valuation
- 29.6×
- –
- –
- 0.9×
- 0.9×
- 13.6×
- 8.1×
- 7.4%
- 3.4%
- 2.6%
Profitability
- 42.6%
- 7.6%
- 3.0%
- –
- 4.2%
- 4.8%
- –
- –
- –
- –
Growth
- +3.3%
- −9.3%
- –
- –
- +0.0%
Financial health
- 2.6×
- 0.72
- –
- 3.2×
- 1.15
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 44%of 957
Bottom 44%of 889
Bottom 43%of 601
Bottom 25%of 884
Top 13%of 986
2.6%of the share price, paid each year
On $1,000 invested$26a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
77.5% of its profit
Room to growStretchedMore than it earns: 35.6%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
43No pass
Benjamin Graham
61Pass
Philip Fisher
33No pass
Peter Lynch
20No pass
Joel Greenblatt
18No pass
Charlie Munger
26No pass
Terry Smith
31No pass
Questions about Arjo
Is Arjo a good stock to buy?
A business with weak numbers at a fair price. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Arjo AI analysis
What does Arjo do?
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and the Pacific. It is in Medical Distribution, based in Malmö, Sweden, with 7,000 employees.
Does Arjo pay a dividend?
Yes. At today's price the dividend is 2.6% a year, about 78% of its yearly profit. In 2025 it paid out SEK 259 million in dividends.
Is Arjo stock halal?
No. Arjo does not pass our halal screen: its debt is 54% of its market value, at or above the 33% limit. How we check
How has Arjo stock done over the past year?
Up 15.7% over the past twelve months, to SEK 36.26. It traded between SEK 23.88 and SEK 36.76, close to its high.
Who are Arjo's competitors?
The largest listed companies in the same industry are McKesson, Cencora, Cardinal Health and Sigma Healthcare. The peers table on this page compares their profit, growth and price with Arjo's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.